BraMARS: An Interpretable Histopathology‐Driven Deep Learning Model for Brain Metastasis Risk Stratification in Surgically Resected Limited‐Stage SCLC
Overall, BraMARS provides a biologically interpretable histopathology‐based framework for estimating subsequent BM risk in resected LS‐SCLC, with potential to support individualized intracranial risk assessment, intensified MRI surveillance, and hypothesis generation for prospective BM‐prevention strategies.